General Information of DTT (ID: TTG68FB)

DTT Name Interleukine 12 (IL-12) DTT Info
Gene Name IL-12

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
6 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ABP 654 DM0GXWT Plaque psoriasis EA90.0 Phase 3 [1]
Ad-RTS-hIL-12 DMCNTFW Glioblastoma of brain 2A00.00 Phase 2 [2]
GEN-1 DMJN09S Ovarian cancer 2C73 Phase 2 [3]
Tavokinogene telseplasmid DMZX0VF Melanoma 2C30 Phase 2 [4]
M9241 DMZUM67 Pancreatic cancer 2C10 Phase 1 [5]
MEDI1191 DMD9OVI Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Clinical Trial Drug(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
YH010 DMA1T66 Aggressive cancer 2A00-2F9Z Investigative [7]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Amgen
2 Clinical pipeline report, company report or official report of Ziopharm Oncology.
3 Clinical pipeline report, company report or official report of Celsion.
4 Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients. Ann Oncol. 2020 Apr;31(4):532-540.
5 Clinical pipeline report, company report or official report of EMD Serono.
6 Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment. Clin Cancer Res. 2020 Dec 1;26(23):6284-6298.
7 Clinical pipeline report, company report or official report of Biocytogen